Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases
National Institutes of Health
At a glance
This funding opportunity is offered by National Institutes of Health. Awards range from $300,000 to $600,000.
Classification and identifiers
- Solicitation number
- PAR-27-109
- Assistance listing (CFDA)
- 93.846
Amount
$300,000 - $600,000
Who can apply
Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;Non-domestic (non-U.S.) Entities (Foreign Institutions).
About this opportunity
The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) intends to publish a Notice of Funding Opportunity (NOFO) to solicit applications for Exploratory Clinical Trials Grants Program in the mission areas of NIAMS. The goal of the NIAMS clinical trial program is to support research leading to the prevention or reduction of symptoms and improve outcomes and function in patients with rheumatic, musculoskeletal, or skin conditions or diseases. The purpose of the Exploratory Clinical Trials Grants Program is to foster clinical trials that will lead to clinically meaningful improvements in prevention, diagnosis, or treatment of these conditions or diseases. This Exploratory Clinical Trials Grants Program is designed to facilitate the execution of short-term, intervent...
Related opportunities
- NIAMS Clinical Trial Implementation Cooperative AgreementNational Institutes of Health
- Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R61 Clinical Trial Required)National Institutes of HealthCloses Nov 2026
- NIH Exploratory/Developmental Research Project Grant (Parent R21 Clinical Trial Required)National Institutes of HealthCloses Jan 2028
- Restoring Joint Health and Function to Reduce Pain (RE-JOIN) 2.0National Institutes of Health
- National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)National Institutes of HealthCloses Jan 2027Up to $500K
- Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required)National Institutes of HealthCloses Jan 2027